Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells

February 3, 2017, University College London
In this electron micrograph, a white blood cell eats an antibiotic resistant bacteria called methicillin-resistant Staphylococcus aureus, or MRSA. Credit: National Institute of Allergy and Infectious Diseases

Antibiotics can still kill drug-resistant bacteria if they 'push' hard enough into bacterial cells, finds new UCL-led research funded by the Engineering and Physical Sciences Research Council.

The study, published in Scientific Reports, opens up a promising new way of overcoming antibiotic resistance and could help scientists to design even more effective drugs.

"Antibiotics work in different ways, but they all need to bind to bacterial cells in order to kill them," explains lead author Dr Joseph Ndieyira (UCL Medicine). "Antibiotics have 'keys' that fit 'locks' on bacterial cell surfaces, allowing them to latch on. When a bacterium becomes resistant to a drug, it effectively changes the locks so the key won't fit any more. Incredibly, we found that certain antibiotics can still 'force' the lock, allowing them to bind to and kill resistant bacteria because they are able to push hard enough. In fact, some of them were so strong they tore the door off its hinges, killing the bacteria instantly!"

The researchers used sensitive equipment to measure the mechanical forces that four different antibiotics exerted on bacterial cells. They tested bacteria that were susceptible to antibiotics and those that had developed resistance. The antibiotics all exerted similar forces on susceptible bacteria, but the forces they exerted on resistant bacteria varied significantly. The antibiotics tested included , a powerful antibiotic used as a last resort treatment for MRSA and other infections, and oritavancin, a modified version of vancomycin used against complex skin infections.

"We found that oritavancin pressed into resistant bacteria with a force 11,000 times stronger than vancomycin," says Dr Ndieyira. "Even though it has the same 'key' as vancomycin, oritavancin was still highly effective at killing . Until now it wasn't clear how oritavancin killed bacteria, but our study suggests that the forces it generates can actually tear holes in the bacteria and rip them apart."

Oritavancin is a fast-acting antibiotic that can kill bacteria in 15 minutes, whereas vancomycin takes 6-24 hours. Vancomycin works by disrupting vital processes in bacteria so they slowly stop functioning and die. Although oritavancin is a modified version of vancomycin, the new study suggests that it kills bacteria in a completely different way.

"Oritavancin molecules are good at sticking together to form clusters, which fundamentally changes how they kill bacteria," explains Dr Ndieyira. "When two clusters dig into a bacterial surface they push apart from each other, tearing the surface and killing the bacteria. Remarkably, we found that conditions at the bacterial surface actually encourage clustering which makes antibiotics even more effective."

The team developed a detailed mathematical model to describe how antibiotics behave at the surface of . The model could be used to screen promising , identifying new drugs that can kill by using brute force.

"Our findings will help us not only to design new antibiotics but also to modify existing ones to overcome resistance," says Dr Ndieyira. "Oritavancin is just a modified version of vancomycin, and now we know how these modifications work we can do similar things with other antibiotics. This will help us to create a new generation of to tackle multi-drug resistant bacterial infections, now recognized as one of the greatest global threats in modern healthcare."

Explore further: NIH advances understanding of defenses against antibiotic-resistant klebsiella bacteria

More information: Scientific Reports, DOI: 10.1038/srep41206

Related Stories

NIH advances understanding of defenses against antibiotic-resistant klebsiella bacteria

January 25, 2017
Klebsiella bacteria cause about 10 percent of all hospital-acquired infections in the United States. K. pneumoniae sequence type 258 (ST258) is one of the Carbapenem-Resistant Enterobacteriaceae organisms labeled an urgent ...

The problem with antibiotics

September 27, 2016
We've all woken up with a sore throat that progresses to a runny nose by the next day. By the third day, we have a hacking cough, a pounding headache from the sinus congestion, and even fevers with chills. We drag ourselves ...

Resistance to antibiotics and to immune system are interconnected in bacteria

June 30, 2016
Antibiotics and the immune system are the two forces that cope with bacterial infections. Now, two studies from Isabel Gordo's laboratory, at Instituto Gulbenkian de Ciência (IGC, Portugal), show for the first time that ...

Answer to antibiotic-resistant infections could already be on the market

April 26, 2016
The rise of antibiotic resistant bacterial pathogens is an increasingly global threat to public health. In the United States alone antibiotic resistant bacterial pathogens kill thousands every year.

Understanding drug-resistant superbugs

July 18, 2016
News reports reveal drug-resistant super bacteria identified as carbapenem-resistant Enterobacteriaceae (CRE) have been found in the waters of Rio de Janeiro where the 2016 Olympics sailing events will be held.

Recommended for you

New inflammation inhibitor discovered

November 16, 2018
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able ...

Gut hormone and brown fat interact to tell the brain it's time to stop eating

November 15, 2018
Researchers from Germany and Finland have shown that so-called "brown fat" interacts with the gut hormone secretin in mice to relay nutritional signals about fullness to the brain during a meal. The study, appearing November ...

Brain, muscle cells found lurking in kidney organoids grown in lab

November 15, 2018
Scientists hoping to develop better treatments for kidney disease have turned their attention to growing clusters of kidney cells in the lab. One day, so-called organoids—grown from human stem cells—may help repair damaged ...

How the Tasmanian devil inspired researchers to create 'safe cell' therapies

November 15, 2018
A contagious facial cancer that has ravaged Tasmanian devils in southern Australia isn't the first place one would look to find the key to advancing cell therapies in humans.

Researchers discover important connection between cells in the liver

November 15, 2018
University of Minnesota Medical School researchers have made a discovery which could lead to a new way of thinking about how disease pathogenesis in the liver is regulated, which is important for understanding the condition ...

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gzurbay
not rated yet Feb 05, 2017
I am curious as to asking researchers from this article if there is any interest in investigating the action prednisone would have if added to any of the afore mentioned antibiotics, considering biofilm formation/destruction.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.